newsfilter
← Latest News
Business Wire·

Cosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN® and Additional Products from Assertio

-- Adds Portfolio of Branded Products with $48.9 million in 2025 Net Sales and an Established Commercial Presence -- -- SYMPAZAN® Establishes a Neurology Rare Disease Footprint within Cosette -- -- Additional